How To Diagnose And Treat Neurofibromatosis Type I

Similar documents
understanding your child's diagnosis of neurofibromatosis a guide for parents

Primary Care for Patients with Neurofibromatosis 1

Facing Neurofibromatosis: A Guide for Teens by Bruce R. Korf, M.D., Ph.D., Gretchen Schneider, M.S., Diana Platt Frenkel, M.S.

Nuno Morais 1 José António Moreira da Costa 2

Neurofibromatosis Type 2: Information for Patients & Families by Mia MacCollin, M.D., Catherine Bove, R.N. Ed. & M. Priscilla Short, M.D.

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

Glossary of Terms Associated with Neurofibromatosis

95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

An individual is considered an incident case only once per lifetime.

DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES

Melanoma The Skin Understanding Cancer

Jennifer A. Defant, M.S., C.G.C. Certified Genetic Counselor Division of Genetics and Metabolism University of Florida

Anatomy: The sella is a depression in the sphenoid bone that makes up part of the skull base located behind the eye sockets.

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Soft Tissue Diffuse Neurofibromas

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

Corporate Medical Policy Reconstructive Eyelid Surgery and Brow Lift

2.1 Who first described NMO?

.org. Osteochondroma. Solitary Osteochondroma

a guide to understanding facial palsy a publication of children s craniofacial association

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Thymus Cancer. This reference summary will help you better understand what thymus cancer is and what treatment options are available.

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Understanding Your Surgical Options For Breast Cancer

International Journal of Health Research

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Fourth Nerve Palsy (a.k.a. Superior Oblique Palsy)

ALBINISM. Other Common Names. Causes/Etiology. Incidence. Characteristics. Hypopigmentation

Corporate Medical Policy Genetic Testing for Fanconi Anemia

EXPANDING YOUR HORIZONS

Introduction to Pathology and Diagnostic Medicine

Interesting Case Series. Periorbital Richter Syndrome

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Getting Ready for ICD-10. Dianna Hoskins, OCS Cincinnati Eye Institute

Analysis of Population Cancer Risk Factors in National Information System SVOD

Accuracy in Space and Time: Diagnosing Multiple Sclerosis Genzyme Corporation, a Sanofi company.

Primary -Benign - Malignant Secondary

Institute of Ophthalmology. Thyroid Eye Disease. aka Thyroid Associated Ophthalmopathy

Molecular Diagnostics in Thyroid Cancer

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

Early Prostate Cancer: Questions and Answers. Key Points

Visual Disorders in Middle-Age and Elderly Patients with Diabetic Retinopathy

MODERN CLINICAL OPTOMETRY BILLING & CODING THE MEDICAL EYE EXAMINATION. Definitions of Eye Examinations. Federal Government Definition

INTRODUCTION TO THE UK CURRICULUM IN CLINICAL GENETICS

F r e q u e n t l y A s k e d Q u e s t i o n s

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

PROTOCOL OF THE RITA DATA QUALITY STUDY

A912: Kidney, Renal cell carcinoma

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

About MS. An introduction to. An introduction to multiple sclerosis for people who have recently been diagnosed. What is MS? Is it common?

Something Old, Something New.

Optic Disc Drusen. Normal Enlarged view of Optic Disc. Lumpy Appearance of Optic Disc. Optic Disc Drusen With Drusen

Genetic Counseling: A Profession in the Making. Jessica Hooks, MS Genetic Counselor University of South Carolina

Multiple Myeloma with Pathologic Fracture: the Role and Treatment Consideration of RT

Malignant Lymphomas and Plasma Cell Myeloma

Understanding your pathology report

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

about Why You Should Know Melanoma

NEW YORK UNIVERSITY SCHOOL OF MEDICINE DEPARTMENT OF OPHTHALMOLOGY SUPERVISION OF RESIDENTS POLICY

Muscular Dystrophy and Multiple Sclerosis. ultimately lead to the crippling of the muscular system, there are many differences between these

H. Fibrous tumors. 17. Intravascular papillary endothelial hyperplasia. 1. Soft fibroma. To Order, Visit the Purchasing Page for Details

A SAFE, NON-INVASIVE TREATMENT OPTION: GAMMA KNIFE PERFEXION

Plastic Surgery - Exceptional Referrals Patient Pathway April 2005

Pediatric Oncology for Otolaryngologists

Thyroid Eye Disease. Anatomy: There are 6 muscles that move your eye.

Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery

A Rare Image. Dean M. Cestari, MD Fred Jakobiec, MD Fred Hochberg, MD Joseph F. Rizzo III, MD Rebecca C. Stacy, MD PhD

Juvenile Dermatomyositis Joseph Junewick, MD FACR

New perception of disability including cognition, fatigue, pain and other impairments related to MS

Cataracts. Cataract and Primary Eye Care Service Main Number Physician Referral AT-WILLS

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL

Basal Cell Carcinoma Affecting the Eye Your Treatment Explained

CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA

ACUTE MYELOID LEUKEMIA (AML),

Blepharoplasty & Cosmetic eyelid surgery

Developmental delay and Cerebral palsy. Present the differential diagnosis of developmental delay.

Statement for the Record for the September 25, 2008, hearing entitled, Cell Phone Use and Tumors: What the Science Says

Course Curriculum for the Master Degree in Dentistry/Orthodontics

Skin cancer Patient information

Congenital Melanocytic Naevi

Diagnostic Scoring System for LQTS

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

Multifocal Motor Neuropathy. Jonathan Katz, MD Richard Lewis, MD

Clinical guidance for MRI referral

Understanding. Brain Tumors. Jana, diagnosed in 1999, with her husband, Paul.

Kidney Cancer OVERVIEW

Four Important Facts about Kidney Cancer

NC DIVISION OF SERVICES FOR THE BLIND POLICIES AND PROCEDURES VOCATIONAL REHABILITATION

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Transcription:

DOI: 10.5272/jimab.14-1-2010.63 Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, vol. 14, book 1 A CASE OF NEUROFIBROMATOSIS TYPE 1 Valentina Dimitrova 1, Ivelina Yordanova 1, Verka Pavlova 1, Valentin Valtchev 1, Dimitar Gospodinov 1, Boryana Parashkevova 2, Chavdar Balabanov 2 1 Department of Dermatology and Venereology, 2 Department of Ophthalmology, Medical University Pleven, Bulgaria ABSTRACT Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance. Neurofibromatosis type I (NF-1), known as well as Recklinghausen s disease, is the most common type of the disease accounting 90% of the cases. We present a case of 52-year-old men with NF-1. The disease started in childhood with the appearance of multiple hyperpigmented skin macules. At the age of 46 a lot of cutaneous tumors appeared and started growing bigger all over the body surface. Because of a vision problem due to an upper left eyelid neurofibroma, the patient came for a clinical examination at the age of 52 years. Key words: Neurofibromatosis, Neurofibromatosis type I, Recklinghausen s disease INTRODUCTION Neurofibromatosis (NF) is a term that has been applied to a variety of related syndromes, characterized by neuroectodermal tumors arising within multiple organs and autosomal-dominant inheritance. At least 8 different clinical phenotypes of neurofibromatosis have been identified and are linked to at least two genetic disorders. Neurofibromatosis type I (NF-1) is the most common type of the disease accounting 90% of the cases, and is characterized by multiple café-au-lait spots and the occurrence of neurofibromas along peripheral nerves. CASE REPORT History A 52-year-old man with Neurofibromatosis type I is presented. The disease started in childhood with the appearance of multiple hyperpigmented skin macules. At the age of 46 a lot of cutaneous tumors appeared and started to increase in size all over the body surface especially on the left eyelid. Due to his psychic condition (the patient is mentally retarded after encephalitis in childhood) he has not consulted a doctor. The growth of the fibroma on the upper eyelid of the left eye had caused visual difficulties, which made him seek care. Physical examination Dermatological status: hundreds of soft cutaneous neurofibromas, the largest amount being on the trunk and limbs, ranging from a few millimeters to several centimeters in diameter (fig 2), some of them pedunculated (fig 3); multiple café-au-lait spots with diameter > 1,5 cm (fig 4); axillary and inguinal freckling (fig 5). The mucous membranes were not affected. Ophthalmological status: multiple cutaneous fibromas of different size on eyelids of both eyes (Fig. 6), without inflammation. There was a 1,5 cm fibroma that affected the edge of eyelid and spread approximately 1 cm to the eyelid margin on the lateral part of the upper eyelid of the left eye. The upper eyelid had partial secondary ptosis. Lisch s nodules on the iris of both eyes were without clinical visual involvement (fig 7). Lab and imaging studies, histologic findings and consultations The standard laboratory tests values were in the normal range. X-ray photography and CT are within the normal too. The neurologist did not detect alterations in the central and peripheral nervous system. According to the otologist the acoustic nerve has not been damaged. The histological result confirmed the diagnosis of Neurofibromatosis. DIAGNOSIS The diagnosis NF-1 was made according to the presence of four of the seven diagnostic criteria of the National Institute of Health Consensus Development Conference: Five or more cafe-au-lait spots larger than 5 mm in diameter in prepubertal patients; six or more café-au-lait spots larger than 15 mm in diameter in postpubertal patients Two or more neurofibromas of any type, or one plexiform neurofibroma Axillary or inguinal freckling Two or more Lisch s nodules Therapy Because of the restriction in the peripheral visual field of the left eye due to the large tumor on the upper eyelid, / JofIMAB 2008, vol. 14, book 1 / 63

the patient was hospitalized in the Ophthalmologic clinic in Pleven for excision of the tumor, which was successful and achieved a good cosmetic result. The material left after excision was sent for histological examination. After the excision, the configuration of upper eyelid was restored and peripheral vision of left eye - which was the main complain of the patient was improved. DISCUSSION Manifestations of neurofibromatosis have been observed for a long time before being described by Robert William Smith in 1849 1. The classic description is by a German pathologist, Friedrich Daniel von Recklinghausen, who accurately described the diverse findings as a single entity in 1882 2 ; thus the condition is often referred to as von Recklinghausen s disease (fig 1). There is no single commonly accepted classification. According to the most widely accepted classification, there are four recognized forms of neurofibromatosis: von Recklinghausen s neurofibromatosis (or neurofibromatosis type 1 [NF-1] or peripheral neurofibromatosis) Bilateral acoustic neurofibromatosis (or neurofibromatosis type 2 [NF-2] or central neurofibromatosis) Segmental neurofibromatosis Cutaneous neurofibromatosis Riccardi 3 suggested the presence of three additional forms: type 3 (mixed), type 4 (variant) and type 5 (late-onset). However, these may not represent separate conditions. The neurofibromatosis comprise of at least two separate genetic disorders (NF-1 and NF-2) characterized by the formation of tumours surrounding nerves and a variety of other pathological features. As many as six additional types have been proposed to characterize what appear to be clinically distinct conditions within this group. The most common type (NF-1) accounting for 90% of cases, is characterized by multiple cafe-au-lait spots and the occurrence of neurofibromas along peripheral nerves. Cutaneous neurofibromas are soft, flesh- or lilac-pinkcoloured tumours, sessile or dome-shaped, sometimes pedunculated, and most numerous on the trunk and limbs. Other clinical features include Lisch s nodules (melanocytic pigmented iris hamartomas) and oral lesions. Possible complications in childhood include the development of an optic glioma, endocrine disturbances and involvement of the lower urinary tract. The children may also present with learning disabilities. Von Recklinghausen s neurofibromatosis (NF-1) is inherited in an autosomal-dominant fashion and has a prevalence of between 1 per 3000 4 and 1 per 5000 5 live births thus being one of the most common autosomal-dominant conditions in humans. The penetrance of NF-1, or the proportion of people with the NF1 gene with a clinical presentation of the disorder, is close to 100% but because the mutation rate is so high, about a half of the newly diagnosed cases may represent with new mutations. The gene has been isolated to the proximal long arm of chromosome 17 (17, 11.2). Diagnostic Criteria According to the National Institute of Health Consensus Development Conference 6, at least two of the following criteria must be present to make the diagnosis of NF-1: 1. Five or more cafe-au-lait spots larger than 5 mm in diameter in prepubertal patients; six or more cafe-au-lait spots larger than 15 mm in diameter in postpubertal patients 2. Two or more neurofibromas of any type, or one plexiform neurofibroma 3. Axillary or inguinal freckling 4. Optic glioma 5. Two or more Lisch s nodules 6. A distinctive osseous lesion (pseudoarthrosis of the tibia or sphenoid wing dysplasia) 7. A first-degree relative diagnosed with NF-1 in accordance with the above criteria Plexiform neurofibromas of the orbit tend to originate from the orbital branches of the trigeminal nerve. They often affect the upper eyelid, causing a characteristic sinusoidal deformity of the lid margin. 7 The tumor is soft and feels like a bag of worms ; the resultant displacement of the globe or ptosis can result in amblyopia in children. Plexiform neuromas of the orbit are associated with congenital absence of the sphenoid or enlargement of the sella turcica. Peripheral neurofibromas are benign tumors consisting predominately of Schwann s cells and fibroblasts with endothelial, perineural, and mast cells. 8 There is evidence that they have a single-cell origin despite multiple cell types within the tumors. 9 Plexiform neurofibromas occur in about one third of NF-1 cases, most commonly on the trunk and less often on the limbs, head and neck. They are benign and rarely symptomatic, but they can cause significant cosmetic and visual problems if the orbit is involved. Caféau-lait spots are composed of epidermal melanocytes with giant pigment granules (macromelanosomes) within the cytoplasm and are of neural crest origin. They are not pathognomonic of neurofibromatosis, having been reported in association with several other conditions and in patients not affected by the condition. 10 Hamartomas of the iris (melanocytic nevi) can be seen and are called Lisch nodules. They are variable in size and have a smooth, dome-shaped configuration. 11 One study found these nodules in 92% of the affected population over the age of 6 years; this may mean that their absence prior to that age does not rule out their later occurrence. Lisch nodules may also be seen in the trabecular meshwork. 12 In a more recent study, the incidence of Lisch nodules in 64 / JofIMAB 2008, vol. 14, book 1 /

patients with neurofibromatosis beyond the second decade of life, was 100%. 13 Lisch nodules, which can be indicative of Neurofibromatosis 1 when multiple, are rarely seen in Neurofibromatosis 2. 14 Although clinical findings are primarily Neurocutaneous in nature, any organ system can be involved. The diagnosis requires six or more cafe au lait cafe-au-lait spots, each larger than 1,5 cm in diameter. Axillary freckling is also highly suggestive of the diagnosis. 15, 16 Areas of hypopigmentation or hyperpigmentation can also be seen. CONCLUSION The patient described here is a very typical case of NF-1, which presents a considerable interest because of the high generalization of the skin lesion. In such cases, a detailed patient investigation is required, because of the possibility for generalized involvement of other organs. The proper clinical and genealogic analysis is important for the determination of the genetic risk and prognosis for the relatives of the proband. The treatment of such kind of patient is surgical, seeking to achieve cosmetic improvement, and may be only palliative. Fig. 2: Cutaneous neurofibromas Fig. 3: Plexiform neurofibromà Fig. 1: The patient original described from von Recklinghausen / JofIMAB 2008, vol. 14, book 1 / 65

fig 4: Café-au-lait spot Fig. 6: Cutaneous fibromas on eyelids Fig. 5: Axillary freckling Fig 7: Lisch s nodules 66 / JofIMAB 2008, vol. 14, book 1 /

BIBLIOGRAPHY 1. Kobrin JL, Blodi FC, Weingeist TA: Ocular and orbital manifestations of neurofibromatosis. Surv Ophthalmol 24:45, 1979 2. von Recklinghausen FD: Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Berlin, Hirschwald, 1882 3. Riccardi VM: Neurofibromatosis: Clinical heterogeneity. Curr Probl Cancer 7:1, 1982 4. Crowe FW, Schull WJ, Neel JV: A clinical, pathological, and genetic study of multiple neurofibromatosis. Springfield, IL, Charles C Thomas, 1956 5. Huson SM, Harper PS, Compston D: Von Recklinghausen neurofibromatosis: a clinical and population study in South- East Wales. Brain 111:1355, 1988 6. National Institutes of Health Consensus Development Conference: Neurofibromatosis. Arch Neurol Chicago 45: 575, 1988 7. Smith B, English FP: Classical eyelid border sign of neurofibromatosis. Br J Ophthalmol 54:134, 1970 8. Riccardi VM, Eichner JE: Neurofibromatosis: phenotype, Natural History and Pathogenesis. Baltimore, Johns Hopkins University Press, 1986 9. Skuse GR, Kosciolek BA, Rowley PT: The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet 49:600, 1991 10. Slater C, Hayes M, Saxe N et al: Macromelanosomes in the early diagnosis of neurofibromatosis. Am J Dermatopathol 8:284, 1986 11. Lewis RA, Riccardi VM: von Recklinghausen neurofibromatosis: Incidence of iris hamartomata. Ophthalmology 88:348, 1981 12. Yanoff M, Fine BS: Ocular Pathology, 2nd ed. Philadelphia, Harper & Row, 1982 13. Lubs ME, Bauer MS, Formas ME, Djokic B: Lisch nodules in neurofibromatosis type 1. N Engl J Med 324:1264, 1991 14. Lubs ME, Bauer MS, Formas ME, Djokic B: Lisch nodules in neurofibromatosis type 1. N Engl J Med 324:1264, 1991 15. Crowe FW: Axillary freckling as a diagnostic aid in neurofibromatosis. Ann Intern Med 61:1142, 1964 16. Smith DW: Recognizable Patterns of Human Malformation. Philadelphia, WB Saunders, 1982 Address for correspondence: Dr. Valentina Dimitrova Department of Dermatology and Venereology, Medical University of Pleven 91, Gen. Vladimir Vazov str., 5800 Pleven, Bulgaria Tel./Fax: +359 64 886 622; E-mail: valentinadim@gmail.com / JofIMAB 2008, vol. 14, book 1 / 67